SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
121.0 |
mmHg |
2.1 |
5.14 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102305 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
126.0 |
mmHg |
1.5 |
3.67 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102309 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 11 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
160.0 |
mmHg |
2.7 |
8.95 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102299 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
129.0 |
mmHg |
2.9 |
7.1 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102296 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 11 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
179.0 |
mmHg |
5.5 |
18.24 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102303 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 11 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
146.0 |
mmHg |
2.1 |
6.96 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102295 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
131.0 |
mmHg |
4.5 |
11.02 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102297 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 11 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
139.0 |
mmHg |
1.4 |
4.64 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102291 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
124.0 |
mmHg |
4.4 |
10.78 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102293 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 10 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
140.0 |
mmHg |
2.7 |
8.54 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102294 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 10 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
152.0 |
mmHg |
4.4 |
13.91 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102298 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
124.0 |
mmHg |
3.2 |
7.84 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102300 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
122.0 |
mmHg |
1.3 |
3.18 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102301 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 10 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
164.0 |
mmHg |
4.9 |
15.5 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102302 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
120.0 |
mmHg |
2.2 |
5.39 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102304 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 10 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
168.0 |
mmHg |
5.3 |
16.76 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102306 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 11 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
180.0 |
mmHg |
5.7 |
18.9 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102307 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
125.0 |
mmHg |
2.0 |
4.9 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102308 |
2661 |
SS/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 10 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
139.0 |
mmHg |
2.7 |
8.54 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102290 |
2661 |
SR/Jr |
systolic blood pressure |
controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours) |
Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31. |
arterial blood pressure trait |
male |
0 days
| 6 |
mean of 3 samples of undefined duration between 7am and 12pm |
serial mean |
120.0 |
mmHg |
2.0 |
4.9 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
0.0 |
0 |
102292 |
2661 |